Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
about the author
Max Bayer
Pharma Reporter
mbayer@endpointsnews.com
author articles
Pfizer looking to sell hospital drugs unit — reports
6 months ago
Pharma
AstraZeneca CEO reaffirms commitment to China following executive's detention
6 months ago
China
Pharma
Intercept is denied full FDA approval for Ocaliva, but claims it will keep drug on market
6 months ago
Pharma
FDA+
FDA lifts hold on Novavax vaccines after adverse event reclassified as ALS
6 months ago
R&D
Pharma
GSK leaves biotech trade group BIO
6 months ago
Pharma
Eisai slashes Leqembi sales forecast by almost $100M
6 months ago
Pharma
Senior AstraZeneca exec detained in China amid wider investigation
6 months ago
People
China
Soft RSV sales reveal a vaccine market failing to catch post-Covid momentum
6 months ago
Pharma
FDA+
Moderna reports slow start to RSV sales as Bancel steps back from commercial role
6 months ago
People
Pharma
One biotech is looking to lessen antipsychotic-induced weight gain, despite new entrants
6 months ago
R&D
Is there room for MASH drugs in a GLP-1 world?
6 months ago
R&D
Pharma
Novo Nordisk claims late-stage MASH victory, continuing GLP-1's expansion
6 months ago
R&D
Compass Pathways delays key Phase 3 psilocybin readouts, spurring 30% layoffs
6 months ago
R&D
Pfizer shares new details on obesity pipeline, hints at ‘other opportunities’
6 months ago
R&D
Pharma
Updated: Pfizer’s Covid pill powers guidance raise, but shortfall elsewhere raises questions
6 months ago
Pharma
BeiGene executive reportedly under investigation in China
6 months ago
China
Pharma
Novartis pays Monte Rosa $150M for Phase 1 drug in latest endorsement of molecular glues
6 months ago
Deals
CDC advisors decline to recommend RSV shots to younger at-risk adults, affirming prior guidance
7 months ago
Pharma
FDA+
Icon's quarterly earnings hit by biotech and pharma pullback
7 months ago
R&D
Outsourcing
Adults 50 and up should get pneumococcal vaccine, CDC advisors say, in boost to Pfizer and Merck
7 months ago
Pharma
FDA+
Pfizer wins approval to expand RSV vaccine to adults at higher infection risk
7 months ago
Pharma
FDA+
Starboard's Kenvue complaints are much different than those aimed at Pfizer
7 months ago
Pharma
Updated: Pfizer's activist says board must 'hold management accountable' for R&D shortcomings
7 months ago
Pharma
Starboard takes activist stake in J&J consumer spinout Kenvue
7 months ago
Pharma
First page
Previous page
4
5
6
7
8
9
10
Next page
Last page
